MedTrace Logo

Prospective Tolerability Assessment of a Probiotic Dietary Supplement

NCT04044144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-04-06

No results posted yet for this study

Summary

The dietary supplement being investigated is a formula containing a combination of eight probiotic strains. The combination formula was developed to support general gastrointestinal and immune health. Each of the strains in the formula have previously been studied in human subjects, including several clinical populations. However, the present eight strain combination formula has not previously been evaluated in human subjects. This prospective study will evaluate the tolerability of the eight strain formula in healthy adults.

Conditions

  • Healthy Adults

Interventions

DIETARY_SUPPLEMENT

Probiotic Dietary Supplement

Dietary supplement containing a combination of 8 probiotic strains

Sponsors & Collaborators

  • National University of Natural Medicine

    collaborator OTHER

  • Metagenics, Inc.

    lead INDUSTRY

Principal Investigators

  • Noelle Patno, PhD · Metagenics, Inc.

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-12
Primary Completion
2019-08-23
Completion
2019-08-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04044144 on ClinicalTrials.gov